羟基氯喹检测方法的进展研究
Progress Research on Hydroxychloroquine Detection Methods
摘要: 羟基氯喹被广泛认知为在治疗疟疾和系统性红斑狼疮过程中起重要作用。然而,随着羟基氯喹(HCQ)的不受控使用,其在环境中的含量的迅速增加可能对水生生物造成严重问题。研究表明,HCQ存在于正常海水生态系统中,并证实了其在植被和地下水中的高持久性和生物积累,为了对海水中羟基氯喹含量进行检测并对其作为污染物潜力的研究,我们需要开发一种用于定量和监测HCQ的传感器。随着技术的发展,人们使用了许多分析方法来检测,包括通过包括高效液相色谱法(HPLC)、电化学法、液相色谱–质谱法(LC-MS)、荧光和比色平台双模式光学检测等等。尽管如此,这些分析方法显示出各种困难。所以研究出一种方法,使其可以快速、灵敏、环保地检测出羟基氯喹成为了一个很值得研究的课题。
Abstract: Hydroxychloroquine is widely recognized as playing an important role in the treatment of malaria and systemic lupus erythematosus. However, with the uncontrolled use of hydroxychloroquine (HCQ), its rapid increase in levels in the environment may cause serious problems for aquatic life. Research shows that HCQ exists in normal seawater ecosystems and confirms its high persistence and bioaccumulation in vegetation and groundwater. In order to detect the content of hydroxychloroquine in seawater and study its potential as a pollutant, we need Development of a sensor for quantification and monitoring of HCQ. With the development of technology, many analytical methods have been used for detection, including high-performance liquid chromatography (HPLC), electrochemical methods, and liquid chromatography-mass spectrometry (LC-MS), fluorescence and colorimetric platforms and pattern optical detection and more. Nonetheless, these analytical methods display various difficulties. Therefore, developing a method that can detect hydroxychloroquine quickly, sensitively, and environmentally friendly has become a worthy research topic.
文章引用:岳圣尧, 葛星爱, 才欣宇, 陈莹莹, 刘宇轩, 闵瑾雯, 钱昆, 方芳, 王司淇. 羟基氯喹检测方法的进展研究[J]. 环境保护前沿, 2024, 14(3): 569-574. https://doi.org/10.12677/aep.2024.143078

参考文献

[1] Ferraz, L.R.M., Santos, F.L.A., Ferreira, P.A., et al. (2014) Quality by Design in the Development and Validation of Analytical Method by Ultraviolet-Visible Spectrophotometry for Quantification of Hydroxychloroquine Sulfate. International Journal of Pharmaceutical Sciences and Research, 5, 4666.
[2] Carr, R.E., Henkind, P., Rothfield, N. and Siegel, I.M. (1968) Ocular Toxicity of Antimalarial Drugs. American Journal of Ophthalmology, 66, 738-744. [Google Scholar] [CrossRef] [PubMed]
[3] Xu, C., Zhu, L., Chan, T., Lu, X., Shen, W., Madigan, M.C., et al. (2016) Chloroquine and Hydroxychloroquine Are Novel Inhibitors of Human Organic Anion Transporting Polypeptide 1A2. Journal of Pharmaceutical Sciences, 105, 884-890. [Google Scholar] [CrossRef] [PubMed]
[4] Dongre, V.G., Ghugare, P.D., Karmuse, P., Singh, D., Jadhav, A. and Kumar, A. (2009) Identification and Characterization of Process Related Impurities in Chloroquine and Hydroxychloroquine by LC/IT/MS, LC/TOF/MS and NMR. Journal of Pharmaceutical and Biomedical Analysis, 49, 873-879. [Google Scholar] [CrossRef] [PubMed]
[5] Koranda, F.C. (1981) Antimalarials. Journal of the American Academy of Dermatology, 4, 650-655. [Google Scholar] [CrossRef] [PubMed]
[6] Mallhi, T.H., Ahmad, A., Butt, M.H., et al. (2020) Chloroquine and Hydroxychloroquine in COVID-19: Practice Implications for Healthcare Professionals. Journal of College of Physicians and Surgeons Pakistan, 30, 124-128.
[7] Akarsu, S. (2020) Hydroxychloroquine: From Pharmacological Profile to Neglected Adverse Reactions. The Journal of Basic and Clinical Health Sciences, 4, 205-211. [Google Scholar] [CrossRef
[8] Shearer, R.V. and Dubois, E.L. (1967) Ocular Changes Induced by Long-Term Hydroxychloroquine (Plaquenil) Therapy. American Journal of Ophthalmology, 64, 245-252. [Google Scholar] [CrossRef] [PubMed]
[9] Yusuf, I.H., Sharma, S., Luqmani, R. and Downes, S.M. (2017) Hydroxychloroquine Retinopathy. Eye, 31, 828-845. [Google Scholar] [CrossRef] [PubMed]
[10] Marmor, M.F., Kellner, U., Lai, T.Y.Y., Melles, R.B. and Mieler, W.F. (2016) Recommendations on Screening for Chloroquine and Hydroxychloroquine Retinopathy (2016 Revision). Ophthalmology, 123, 1386-1394.
https://doi.o.rg/10.1016/j.ophtha.2016.01.058
[11] Chen, Z., Hu, J., Zhang, Z., et al. (2020) Efficacy of Hydroxychloroquine in Patients with COVID-19: Results of a Randomized Clinical Trial.
[12] Elavarasi, A., Prasad, M., Seth, T., Sahoo, R.K., Madan, K., Nischal, N., et al. (2020) Chloroquine and Hydroxychloroquine for the Treatment of COVID-19: A Systematic Review and Meta-Analysis. Journal of General Internal Medicine, 35, 3308-3314. [Google Scholar] [CrossRef] [PubMed]
[13] Singh, A.K., Singh, A., Singh, R. and Misra, A. (2020) Hydroxychloroquine in Patients with COVID-19: A Systematic Review and Meta-Analysis. Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 14, 589-596. [Google Scholar] [CrossRef] [PubMed]
[14] Farias, D.F., Souza, T., Souza, J.A.C.R., Vieira, L.R., Muniz, M.S., Martins, R.X., et al. (2020) COVID‐19 Therapies in Brazil: Should We Be Concerned with the Impacts on Aquatic Wildlife? Environmental Toxicology and Chemistry, 39, 2348-2350. [Google Scholar] [CrossRef] [PubMed]
[15] Ben Ali, M., Hedfi, A., Almalki, M., Karachle, P.K. and Boufahja, F. (2021) Toxicity of Hydroxychloroquine, a Potential Treatment for COVID-19, on Free-Living Marine Nematodes. Marine Pollution Bulletin, 167, Article ID: 112361. [Google Scholar] [CrossRef] [PubMed]
[16] Patel, M., Kumar, R., Kishor, K., Mlsna, T., Pittman, C.U. and Mohan, D. (2019) Pharmaceuticals of Emerging Concern in Aquatic Systems: Chemistry, Occurrence, Effects, and Removal Methods. Chemical Reviews, 119, 3510-3673. [Google Scholar] [CrossRef] [PubMed]
[17] El Sharkasy, M.E., Tolba, M.M., Belal, F., Walash, M. and Aboshabana, R. (2022) Quantitative Analysis of Favipiravir and Hydroxychloroquine as FDA-Approved Drugs for Treatment of COVID‐19 Using Synchronous Spectrofluorimetry: Application to Pharmaceutical Formulations and Biological Fluids. Luminescence, 37, 953-964. [Google Scholar] [CrossRef] [PubMed]
[18] Bodur, S., Erarpat, S., Günkara, Ö.T. and Bakırdere, S. (2021) Accurate and Sensitive Determination of Hydroxychloroquine Sulfate Used on COVID-19 Patients in Human Urine, Serum and Saliva Samples by GC-MS. Journal of Pharmaceutical Analysis, 11, 278-283. [Google Scholar] [CrossRef] [PubMed]
[19] Xiong, X., Wang, K., Tang, T., Fang, J. and Chen, Y. (2021) Development of a Chiral HPLC Method for the Separation and Quantification of Hydroxychloroquine Enantiomers. Scientific Reports, 11, Article No. 8017. [Google Scholar] [CrossRef] [PubMed]
[20] Qu, Y., Noe, G., Breaud, A.R., Vidal, M., Clarke, W.A., Zahr, N., et al. (2015) Development and Validation of a Clinical HPLC Method for the Quantification of Hydroxychloroquine and Its Metabolites in Whole Blood. Future Science OA, 1, FSO26. [Google Scholar] [CrossRef] [PubMed]
[21] Carvalho, M.S., Rocha, R.G., de Faria, L.V., Richter, E.M., Dantas, L.M.F., da Silva, I.S., et al. (2022) Additively Manufactured Electrodes for the Electrochemical Detection of Hydroxychloroquine. Talanta, 250, Article ID: 123727. [Google Scholar] [CrossRef] [PubMed]
[22] Singh, A., Sharma, P.K., Gupta, R., et al. (2016) Development and Validation of UV-Spectrophotometric Method for the Estimation of Hydroxychloroquine Sulphate.
[23] Ünal Taş, D. (2022) A New Method for Hydroxychloroquine Detection. Middle East Technical University.
[24] Doğan, K., Ünal Taş, D., Persil Çetinkol, Ö. and Forough, M. (2024) Fluorometric and Colorimetric Platforms for Rapid and Sensitive Hydroxychloroquine Detection in Aqueous Samples. Talanta, 270, Article ID: 125523. [Google Scholar] [CrossRef] [PubMed]